Mechanistic studies on Foxp3+ Treg-mediated protumor effects (42) reveal their suppression of CD8+ CTL cytotoxicity and enhancement of tumor invasiveness, with elevated Foxp3+/CD8+ and Foxp3+/CD4+ ratios confirmed as independent risk factors for postoperative recurrence (51). The gene discussed is CD8A; the disease is neoplasm.